Listed companies have less than six years to align with 1.5°C warming target - MSCI

Analysis of more than 9,000 listed companies points to failures

Pedro Gonçalves
clock • 2 min read
Chinese companies feature prominently in the list of companies highlighted as poor performers by MSCI
Image:

Chinese companies feature prominently in the list of companies highlighted as poor performers by MSCI

Publicly listed companies must accelerate climate action if the 1.5°C warming target set out in the 2015 Paris Agreement is to be met, according to a new tracker by index provider MSCI covering more than 9,000 companies.

The inaugural Net-Zero Tracker highlights how the annual emissions of listed companies globally are still at the same level as 2013, despite concerted efforts to place climate change at the top of the...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on ESG

Plummeting battery costs could lead to EVs reaching cost-parity with petrol and diesel cars within three years | Credit: Tesla
ESG

Could plummeting battery costs deliver mass market EVs as soon as 2024?

Electric vehicles could reach cost-parity with petrol and diesel cars

Michael Holder
clock 01 December 2021 • 4 min read
abrd unveils EM debt fund
ESG

abrdn launches EM Sustainable Development Corporate Bond fund

1% AMC for retail share class

clock 01 December 2021 • 1 min read
Partner insight: Engagement with a pharmaceutical company
ESG

Partner insight: Engagement with a pharmaceutical company

In this case study, PIMCO reveals how it engaged the company on a range of Covid-19-related concerns

Gareth Jones
clock 01 December 2021 • 1 min read
Trustpilot